window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 27, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

RBQM

  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Regulatory Affairs

    Transitioning to risk-based clinical trial management under ICH E6(R3)

    Risk-based quality management (RBQM) is becoming central to clinical trial [...]

    February 16, 2026
  • Artificial Intelligence,Digital Health,Healthcare leadership,Movers & Shakers,Pharmaceuticals and therapeutics

    CluePoints names Sinead Godkin CPO to scale global workforce

    CluePoints has appointed Sinead Godkin as chief people officer, strengthening [...]

    January 14, 2026
  • Clinical Development,Clinical studies,Clinical Trials,Data Management,Digital Health,Drug Development,Regulatory Affairs,Technology and platforms

    CluePoints: how proactive oversight and AI are reshaping clinical trial data management

    Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

    January 7, 2026
  • Artificial Intelligence,Clinical Trials,Data Management

    Six geese a-laying: CluePoints’ AI predictions for 2026

    As our Christmas countdown continues, we move from reflections on [...]

    December 18, 2025
  • Clinical Development,Data Management,Technology and platforms

    Today Discover Pharma launches its annual 12 Days of Christmas campaign featuring CluePoints insight on RBQM

    The launch of the 12 Days of Christmas campaign marks [...]

    December 18, 2025
  • Artificial Intelligence,Clinical Trials,Digital Health,Movers & Shakers,Technology and platforms

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    October 6, 2025
  • Artificial Intelligence,Clinical Development,Clinical Trials,Data Management,Drug Delivery & Formulation,Technology and platforms

    eClinical Solutions adds integrated data review plan capabilities to elluminate platform

    Company becomes the first to centralize digital data review activities [...]

    August 21, 2025
  • CDMOs & Manufacturing,Supply Chain & Logistics

    Building resilient pharma supply chains amid increasing tariff volatility

    Amid escalating trade tensions and regulatory complexity, pharma manufacturers are [...]

    June 23, 2025
  • Artificial Intelligence,Clinical Trials,Technology and platforms

    RBQMLive returns in 2025 with agenda on regulation, ROI and AI in clinical trials

    CluePoints releases full speaker lineup for free virtual event focused [...]

    June 23, 2025
  • Artificial Intelligence,Clinical Trials,Regulatory Affairs

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 27, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top